August ’s top stories: Cancer Research UK’s new oncology trial, Novartis’ malaria drug trial

Cancer Research UK initiated a trial of LY3143921 hydrate to treat patients with advanced solid tumours, and Novartis and MMV initiated a Phase IIb trial of KAF156 to treat multidrug-resistant malaria in Africa. Drugdevelopment-technology.com wraps u …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news